Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 207

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects

Bushby, S. R. M. · 1973 · Journal of Infectious Diseases

Abstract

The ultimate effect on bacteria of trimethoprim (TMP) and sulfamethoxazole (SMZ) is to deprive them of folate coenzymes; the spectra of in vitro activity of TMP and SMZ are therefore similar although TMP is usually 20–100 times more active than is SMZ. The synergy of TMP and SMZ can be demonstrated in vitro by increases in bacteriostatic and bactericidal activities. There is an optimal ratio for producing these effects, and it corresponds to the ratios of the MIC of each drug when acting alone; however, synergy does occur over a wide range of ratios. The in vitro activity of TMP-SMZ depends on the medium in which it is measured; traces of thymidine will almost completely abolish activity. The size of the inoculum also affects activity. The activity is not affected in vitro or in vivo by the presence of exogenous folates except in the case of Streptococcus faecalis. Resistance to one of the drugs as measured by conventional tests may not abolish synergy; synergy is maximal, however, when the organism is susceptible to both drugs. Multiple studies have confirmed that TMP-SMZ has a wide spectrum of in vitro activity. The only outstanding exception is Pseudomonas aeruginosa. From heavy inocula, resistance to TMP develops rapidly, but the rate is markedly reduced by the presence of SMZ. The retarding effects of the sulfonamide depend on the degree of susceptibility of the organism and become small with highly resistant strains. R-factors conferring resistance to TMP have been identified, although at present they are rare. Susceptibility testing presents no problems provided a suitable medium and a small inoculum are used. A single combined disk containing 1.25 µg of TMP and 23.75 µg of SMZ is adequate for routine tests.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/128.supplement_3.s442

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 207

Metadata

Authors
Bushby, S. R. M.
Venue
Journal of Infectious Diseases
Published
1973-11-01
Volume
128
Issue
Supplement 3
Pages
S442-S462
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2151619842
Cited by
207
References
1
FWCI
9.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects. https://app.cochat.ai/papers/10.1093/infdis/128.supplement_3.s442
The paper
Bushby, S. R. M. (1973). Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/128.supplement_3.s442

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.